Bank Julius Baer & Co
BLCM

Bank Julius Baer & Co’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Bank Julius Baer & Co’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-120
Closed -$1K – 863
2020
Q3 		$1K Buy
+120
New +$813 ﹤0.01% 733
2020
Q2 		– Sell
-214
Closed -$1K – 758
2020
Q1 		$1K Buy
+214
New +$2.3K ﹤0.01% 635

Other funds holding BLCM

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank Julius Baer & Co's BLCM Position: Q4 2020 in Review

Bank Julius Baer & Co sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2020, closing a stake of 120 shares — an estimated $1K sold.

Bank Julius Baer & Co first reported a position in BLCM in Q1 2020 and held it in 2 quarters. The position peaked at $1K in Q3 2020. 34 funds tracked by Wall St. Rank hold BLCM as of Q4 2020.

  • Bank Julius Baer & Co reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Bank Julius Baer & Co sold 120 Bellicum Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1K.
  • Bank Julius Baer & Co first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2020 and held it in 2 quarters.
  • Bank Julius Baer & Co's Bellicum Pharmaceuticals, Inc. position peaked at $1K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2020.

Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.